Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT01652482 · COMPLETED
Trial details
- NCT number
- NCT01652482
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-11-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.